Table 3.
Characteristics of patients with localized tumors according to antidiabetic medication and statin use.
| Metformin | Insulin | Other ADM | Statin | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Yes (%) | No (%) | Yes (%) | No (%) | Yes (%) | No (%) | Yes (%) | No (%) | Total (%) | |
| Total | 173 (100) | 119 (100) | 105 (100) | 187 (100) | 167 (100) | 125 (100) | 97 (100) | 195 (100) | 292 (100) |
| Sex | |||||||||
| Male | 143 (83) | 92 (77) | 79 (75) | 156 (83) | 139 (83) | 96 (77) | 78 (80) | 157 (81) | 235 (80) |
| Female | 30 (17) | 27 (23) | 26 (25) | 31 (17) | 28 (17) | 29 (23) | 19 (20) | 38 (19) | 57 (20) |
| Education | |||||||||
| Basic | 56 (32) | 28 (24) | 34 (32) | 50 (27) | 51 (31) | 33 (26) | 26 (27) | 58 (30) | 84 (29) |
| Intermediate | 62 (36) | 49 (41) | 39 (37) | 72 (39) | 65 (39) | 46 (37) | 48 (49) | 63 (32) | 111 (38) |
| Higher | 55 (32) | 42 (35) | 32 (30) | 65 (35) | 51 (31) | 46 (37) | 23 (24) | 74 (38) | 97 (33) |
| Follow-up time (years) | |||||||||
| Median | 0.8 | 0.6 | 0.6 | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 |
| Interquartile range | 0.1–2.9 | 0.08–2.4 | 0.06–2.5 | 0.2–2.7 | 0.2–2.9 | 0.08–2.0 | 0.1–2.5 | 0.1–2.8 | 0.1–2.7 |
| Duration of diabetes (years) | |||||||||
| Median | 9.6 | 9.5 | 12.3 | 7.8 | 9.8 | 8.1 | 10.2 | 9.3 | 9.6 |
| Interquartile range | 5.3–13.9 | 6.0–16.0 | 8.2–16.9 | 4.6–12.3 | 6.8–13.9 | 3.7–15.8 | 5.9–15.7 | 5.3–14.2 | 5.3–14.9 |
| Hepatitis | |||||||||
| Yes | 12 (7) | 7 (6) | 9 (9) | 10 (5) | 8 (5) | 11 (9) | 8 (8) | 11 (6) | 19 (7) |
| No | 161 (93) | 112 (94) | 96 (91) | 177 (95) | 159 (95) | 114 (91) | 89 (92) | 184 (94) | 273 (93) |
| Cirrhosis | |||||||||
| Yes | 41 (24) | 31 (26) | 29 (28) | 43 (23) | 43 (26) | 29 (23) | 22 (23) | 50 (26) | 72 (25) |
| No | 132 (76) | 88 (74) | 76 (72) | 144 (77) | 124 (74) | 96 (77) | 75 (77) | 145 (74) | 220 (75) |
| Age at HCC diagnosis (years) | |||||||||
| Median | 71 | 72 | 70 | 72 | 72 | 70 | 73 | 70 | 71 |
| Interquartile range | 65–77 | 64–80 | 63–77 | 65–79 | 66–79 | 63–77 | 66–79 | 63–78 | 65–78 |
ADM = antidiabetic medication, HCC = hepatocellular carcinoma.